These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16202058)

  • 21. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
    Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
    Tomblyn M; Burns LJ; Blazar B; Wagner J; Lee C; Rogers T; McGlave P; Miller JS; Weisdorf DJ
    Bone Marrow Transplant; 2007 Jul; 40(2):111-8. PubMed ID: 17530003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
    Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
    Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
    Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
    López-Holgado N; Pata C; Villarón E; Sánchez-Guijo F; Alberca M; Martín A; Corral M; Sánchez-Abarca I; Pérez-Simón JA; San Miguel JF; del Cañizo MC
    Haematologica; 2005 Mar; 90(3):353-9. PubMed ID: 15749668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors.
    Marmier-Savet C; Larosa F; Legrand F; Witz B; Michallet M; Ranta D; Louvat P; Puyraveau M; Raus N; Tavernier M; Mathieu-Nafissi S; Hequet O; Pouthier F; Deconinck E; Tiberghien P; Robinet E
    Transfusion; 2010 Dec; 50(12):2676-85. PubMed ID: 20663114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
    Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Flandrois G; Devys A; Stocco V; Cesbron A; Dehaut F; Moreau P; Harousseau JL; Mohty M
    Bone Marrow Transplant; 2009 Nov; 44(9):613-5. PubMed ID: 19308036
    [No Abstract]   [Full Text] [Related]  

  • 28. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.
    Ripa RS; Wang Y; Jørgensen E; Johnsen HE; Hesse B; Kastrup J
    Eur Heart J; 2006 Aug; 27(15):1785-92. PubMed ID: 16825290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation.
    Tagami K; Yujiri T; Tanimura A; Mitani N; Nakamura Y; Ariyoshi K; Ando T; Fujii Y; Tanizawa Y
    Br J Haematol; 2006 Nov; 135(4):567-9. PubMed ID: 17054673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors.
    Lee KE; Mun YC; Nam SH; Kwon JM; Lee SM; Lee MA; Yoo ES; Ahn JY; Kim JH; Seong CM
    Bone Marrow Transplant; 2005 Dec; 36(12):1027-31. PubMed ID: 16247428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin.
    Grassinger J; Mueller G; Hart C; Nilsson SK; Haylock DN; Andreesen R; Hennemann B
    Eur J Haematol; 2008 Jan; 80(1):20-30. PubMed ID: 18028434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.
    Heldal D; Brinch L; Tjønnfjord G; Solheim BG; Egeland T; Gadeholt G; Albrechtsen D; Aamodt G; Evensen SA
    Bone Marrow Transplant; 2002 Mar; 29(6):479-86. PubMed ID: 11960266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF.
    Kaplinsky C; Trakhtenbrot L; Hardan I; Reichart M; Daniely M; Toren A; Amariglio N; Rechavi G; Izraeli S
    Bone Marrow Transplant; 2003 Jul; 32(1):31-4. PubMed ID: 12815475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal CD34(+) cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor.
    de la Rubia J; Lorenzo JI; Torrabadella M; Marín P; Insunza A; Sanz MA
    Haematologica; 2004 Dec; 89(12):1530-2. PubMed ID: 15590408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
    Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG
    Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).
    Martino M; Callea I; Condemi A; Dattola A; Irrera G; Marcuccio D; Messina G; Pontari A; Pucci G; Console G; Lacopino P
    J Clin Apher; 2006 Oct; 21(3):169-75. PubMed ID: 16532489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.